Literature DB >> 22956494

DNA methyltransferases, DNA damage repair, and cancer.

Bilian Jin1, Keith D Robertson.   

Abstract

The maintenance DNA methyltransferase (DNMT) 1 and the de novo methyltransferases DNMT3A and DNMT3B are all essential for mammalian development. DNA methylation, catalyzed by the DNMTs, plays an important role in maintaining genome stability. Aberrant expression of DNMTs and disruption of DNA methylation patterns are closely associated with many forms of cancer, although the exact mechanisms underlying this link remain elusive. DNA damage repair systems have evolved to act as a genome-wide surveillance mechanism to maintain chromosome integrity by recognizing and repairing both exogenous and endogenous DNA insults. Impairment of these systems gives rise to mutations and directly contributes to tumorigenesis. Evidence is mounting for a direct link between DNMTs, DNA methylation, and DNA damage repair systems, which provide new insight into the development of cancer. Like tumor suppressor genes, an array of DNA repair genes frequently sustain promoter hypermethylation in a variety of tumors. In addition, DNMT1, but not the DNMT3s, appear to function coordinately with DNA damage repair pathways to protect cells from sustaining mutagenic events, which is very likely through a DNA methylation-independent mechanism. This chapter is focused on reviewing the links between DNA methylation and the DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22956494      PMCID: PMC3707278          DOI: 10.1007/978-1-4419-9967-2_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  147 in total

1.  MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.

Authors:  A Bellacosa; L Cicchillitti; F Schepis; A Riccio; A T Yeung; Y Matsumoto; E A Golemis; M Genuardi; G Neri
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 2.  Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America.

Authors:  Megan A Murphy; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2011-04-04       Impact factor: 7.396

3.  Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.

Authors:  Heba Mohamed Tawfik; Nehad M R Abd El-Maqsoud; Balegh H A Abdel Hak; Yasser M El-Sherbiny
Journal:  Am J Otolaryngol       Date:  2011-02-24       Impact factor: 1.808

4.  Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.

Authors:  Cathy B Moelans; Anoek H J Verschuur-Maes; Paul J van Diest
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

5.  DNA hypomethylation leads to elevated mutation rates.

Authors:  R Z Chen; U Pettersson; C Beard; L Jackson-Grusby; R Jaenisch
Journal:  Nature       Date:  1998-09-03       Impact factor: 49.962

6.  Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles.

Authors:  Jessie Auclair; Thomas Vaissière; Françoise Desseigne; Christine Lasset; Valérie Bonadona; Sophie Giraud; Jean-Christophe Saurin; Marie-Odile Joly; Dominique Leroux; Laurence Faivre; Carole Audoynaud; Gilles Montmain; Eric Ruano; Zdenko Herceg; Alain Puisieux; Qing Wang
Journal:  Genes Chromosomes Cancer       Date:  2010-12-09       Impact factor: 5.006

7.  Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.

Authors:  J M Wheeler; N E Beck; H C Kim; I P Tomlinson; N J Mortensen; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

8.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

Authors:  M Esteller; S R Hamilton; P C Burger; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

9.  The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.

Authors:  Quynh N Vo; Wan-Ju Kim; Luke Cvitanovic; Donald A Boudreau; David G Ginzinger; Kevin D Brown
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

10.  Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines.

Authors:  N Kato; H Fujimoto; A Yoda; I Oishi; N Matsumura; T Kondo; J Tsukada; Y Tanaka; M Imamura; Y Minami
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

View more
  152 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer.

Authors:  Min-Li Mo; Jie Ma; Zhao Chen; Bing Wei; Hui Li; Yong Zhou; Huaiyin Shi; Bhairavi Tolani; Joy Q Jin; Hsin-Hui Tseng; Dong Shen; Yi Zhan; Jun Li; David M Jablons; Rong-Qing Zhang; Yongjun Guo; Biao He; Hai-Meng Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-04       Impact factor: 4.553

3.  LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.

Authors:  C Zhou; C Huang; J Wang; H Huang; J Li; Q Xie; Y Liu; J Zhu; Y Li; D Zhang; Q Zhu; C Huang
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

4.  Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer.

Authors:  Youqiang Fang; Jieying Wu; Tengcheng Li; Yun Luo; Qiyu Qiu; Xinxin Quan; Li Gao; Wei Liu
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

5.  Age-related macular degeneration (AMD) mitochondria modulate epigenetic mechanisms in retinal pigment epithelial cells.

Authors:  Sonali Nashine; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Exp Eye Res       Date:  2019-06-19       Impact factor: 3.467

Review 6.  Targeting the epigenome in malignant pleural mesothelioma.

Authors:  Kaitlin C McLoughlin; Andrew S Kaufman; David S Schrump
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 7.  SOX1 Is a Backup Gene for Brain Neurons and Glioma Stem Cell Protection and Proliferation.

Authors:  Kouminin Kanwore; Xiao-Xiao Guo; Ayanlaja Abiola Abdulrahman; Piniel Alphayo Kambey; Iqra Nadeem; Dianshuai Gao
Journal:  Mol Neurobiol       Date:  2021-01-22       Impact factor: 5.590

8.  Decreased DNA Methylations at the Progesterone Receptor Promoter A Induce Functional Progesterone Withdrawal in Human Parturition.

Authors:  Xia Li; Cheng Chen; Hui Luo; Jennifer C van Velkinburgh; Bing Ni; Qing Chang
Journal:  Reprod Sci       Date:  2014-01-08       Impact factor: 3.060

9.  Of mice and men: correlations between microRNA-17∼92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia.

Authors:  Mary E Robbins; Duaa Dakhlallah; Clay B Marsh; Lynette K Rogers; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

Review 10.  Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.

Authors:  Manuela Terranova-Barberio; Scott Thomas; Pamela N Munster
Journal:  Immunotherapy       Date:  2016-06       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.